AwardTape · Defense awards · Research and development · Health R&D · W81XWH20P0119
W81XWH20P0119: $27K purchase order to Zen-Bio, Inc
Zen-Bio, Inc holds a purchase order from Defense Health Agency with $27K obligated since Oct 2023 and $179K obligated over its life, against a ceiling of $198K. Latest action Sep 18, 2025.
Screened human serum - a+
| PIID | W81XWH20P0119 |
|---|---|
| Type | purchase order |
| Company | Zen-Bio, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN11 HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH |
| NAICS | 325414 BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING |
| Obligated since Oct 2023 | $27K |
| Total obligated (lifetime) | $179K |
| Ceiling (base and all options) | $198K |
| Base date | Aug 15, 2020 |
| Latest action | Sep 18, 2025 |
| End date | Aug 14, 2025 |
| Actions since Oct 2023 | 2 |
| Pricing | Firm fixed price |
| Competition | Not competed |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial